| View |
|
DR-XY43703
|
Gliclazide
|
Glucron
|
80 mg
|
Modified-Release Tablet
|
Oral Hypoglycemic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
23 June 2024
|
03 September 2029
|
| View |
|
DR-XY43707
|
Hydrochlorothiazide
|
Diozide
|
25 mg
|
Film-coated tablet
|
Diuretic
|
Concept Pharmaceuticals Ltd.
|
India
|
Renewal
|
01 July 2024
|
09 September 2029
|
| View |
|
DR-XY43715
|
Levocetirizine Dihydrochloride
|
Lecetzy
|
5 mg
|
Film Coated Tablet
|
Antihistamine
|
Zee Laboratories
|
India
|
Renewal
|
25 July 2024
|
05 September 2029
|
| View |
|
DR-XY43728
|
Cefuroxime (as axetil)
|
Cefovex-250
|
250 mg
|
Film-Coated Tablet
|
Antibacterial
|
Oman Pharmaceutical Products Co., L.L.C.
|
Oman
|
Renewal
|
23 August 2024
|
15 September 2029
|
| View |
|
DR-XY43731
|
ETORICOXIB
|
Ecoxib
|
120mg
|
Film-Coated Tablet
|
Selective COX-2 Inhibitor
|
Aurochem Laboratories
|
India
|
Renewal
|
28 August 2024
|
24 September 2029
|
| View |
|
DR-XY43732
|
ETORICOXIB
|
ECOXIB
|
90mg
|
Film-Coated Tablet
|
Selective COX-2 Inhibitor
|
Aurochem Laboratories
|
India
|
Renewal
|
11 August 2024
|
11 September 2029
|
| View |
|
DR-XY43734
|
ETORICOXIB
|
ECOXIB
|
60mg
|
Film-Coated Tablet
|
Selective COX-2 Inhibitor
|
Aurochem Laboratories
|
India
|
Renewal
|
11 August 2024
|
11 September 2029
|
| View |
|
DR-XY43741
|
Clindamycin (as phosphate)
|
Akneclin
|
10 mg/g (1% w/w
|
Topical Gel
|
Antibacterial
|
Zee Laboratories Ltd.
|
India
|
Renewal
|
04 August 2024
|
24 November 2029
|
| View |
|
DR-XY43743
|
Clobetasol Propionate
|
None
|
500mcg/ g (0.05%w/w)
|
OINTMENT
|
Anti-inflammatory/Antipruritic
|
DS Cosmeceutical Manufacturing Laboratory
|
Philippines
|
Automatic Renewal
|
18 August 2021
|
22 September 2026
|
| View |
|
DR-XY43752
|
Carboxymethylcellulose (As Sodium)
|
Optear
|
5 mg/mL (0.5%)
|
Ophthalmic Solution (Eye Drops)
|
Ophthalmic Lubricant
|
Amanta Healthcare Ltd.
|
India
|
Renewal
|
27 September 2024
|
26 September 2029
|
| View |
|
DR-XY43753
|
Cefepime (as hydrochloride)
|
Altamax
|
1g
|
Powder For Injection (Im/Iv)
|
Antibacterial (Cephalosporin)
|
Taiwan Biotech Co., Ltd.
|
Taiwan
|
Renewal
|
05 May 2024
|
26 September 2029
|
| View |
|
DR-XY43754
|
Paracetamol
|
Paragesic
|
125 mg
|
Rectal Suppository
|
Analgesic / Antipyretic
|
Bliss GVS Pharma Ltd.
|
India
|
Renewal
|
14 June 2024
|
26 September 2029
|
| View |
|
DR-XY43756
|
Gliclazide
|
Unbranded
|
30 mg
|
Modified-Release Tablet
|
Oral Hypoglycemic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
21 October 2024
|
26 September 2029
|
| View |
|
DR-XY43759
|
Lipid Emulsion + Amino Acid + Electrolytes + Glucose
|
Combiflex Lipid Central
|
(See Attachment for Formulation)
|
Emulsion For Intravenous Infusion (IV)
|
Parenteral Nutrition
|
JW Life Science Corporation
|
Korea
|
Renewal
|
02 November 2024
|
26 September 2029
|
| View |
|
DR-XY43760
|
Lipid Emulsion + Amino Acids + Electrolytes + Glucose
|
Combiflex Lipid Peri
|
[see reverse]
|
Emulsion for IV Infusion
|
Parenteral Nutrition
|
JW Life Science Corporation
|
Korea
|
Automatic Renewal
|
24 December 2021
|
20 February 2027
|
| View |
DR-XY43762_PI_01.pdf
|
DR-XY43762
|
Meropenem (as trihydrate)
|
Natronem
|
1 g
|
Powder for Injection (IV)
|
Antibacterial
|
Samjin Pharmaceutical Co., Ltd.
|
Korea
|
Renewal
|
11 August 2024
|
29 October 2029
|
| View |
DR-XY43763_PI_01.pdf
|
DR-XY43763
|
Meropenem (as trihydrate)
|
Natronem
|
500 mg
|
Powder for Injection (IV)
|
Antibacterial
|
Samjin Pharmaceutical Co., Ltd.
|
Korea
|
Renewal
|
28 August 2024
|
29 October 2029
|
| View |
DR-XY43764_PI_01.pdf
|
DR-XY43764
|
Axitinib
|
Inlyta
|
5 mg
|
Film-Coated Tablet
`
|
Tyrosine Kinase Inhibitor
|
Pfizer Manufacturing Deutschland GmbH
|
Germany
|
Renewal
|
28 August 2024
|
02 October 2029
|
| View |
DR-XY43765_PI_01.pdf
|
DR-XY43765
|
Axitinib
|
Inlyta
|
1 mg
|
Film-Coated Tablet
|
Tyrosine Kinase Inhibitor
|
Pfizer Manufacturing Deutschland GmbH
|
Germany
|
Renewal
|
06 August 2024
|
02 October 2029
|
| View |
|
DR-XY43766
|
Ceftazidime (as Pentahydrate)
|
Auromitaz 1000
|
1g
|
Powder for Injection
|
Antibacterial (Cephalosporin)
|
Aurobindo Pharma Limited
|
India
|
Automatic Renewal
|
21 September 2021
|
03 October 2026
|